Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email firstname.lastname@example.org.
Check back regularly for news, coverage, and announcements about MAVA.
River Cities Capital Funds, a growth equity firm investing in high-potential healthcare and IT companies, is pleased to announce the final closing of its fifth fund. Fund V has reached a $200 million hard cap.
Cyber Squared Inc. announced today that ThreatConnect, the leading threat intelligence platform, has launched a European Community of Interest.
In the first quarter of 2014, Salsa Labs, Inc.(Salsa) nonprofit clients raised $9,471,492 through Salsa's platform that helps nonprofits grow, engage and retain their base of online support.
Ceterix Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, announced that the company has closed $18 million in new financing.
Wellington Financial LP, a privately-held specialty finance firm, today announced a $5 million expansion financing for Agiliance® , Inc.
New Enterprise Associates (NEA), the Chevy Chase-based venture capital firm, has led a new $23.6 million round of funding for Seattle-based data center infrastructure startup Igneous Systems, the company announced.
The DC region is a hub for cybersecurity expertise and one California company’s recent acquisitions show it's also a good place to shop.
AOL Inc. (NYSE: AOL) today announced the continued strategic investment in its programmatic platforms by entering into an agreement to acquire Convertro Inc., a leading provider of multi-touch attribution modeling technology for brands and agencies.
Baltimore software startup Rehabtics LLC is the winner of Towson University’s annual business competition.
Biocept, Inc., a molecular diagnostics company specializing in oncology biomarker detection and monitoring through circulating tumor cells (CTCs) and cell-free circulating tumor DNA, today announced that it has closed a loan facility of up to $10 million (the "facility") with Oxford Finance LLC ("Oxford").